3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Glioma
4
Wilms Tumor
2
Urothelial Cancer
2
Rhabdoid Tumor
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Multiple Myeloma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Carcinoma, Transitional Cell
2
Xanthogranuloma, Juvenile
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Interventions
Gemcitabine
16
Cisplatin
14
pembrolizumab
10
durvalumab
10
Oxaliplatin
8
Magnetic Resonance Spectroscopy
8
Specimen Handling
6
Leucovorin
6
Biopsy
6
Fluorouracil
5
Paclitaxel
4
Folfox protocol
4
fludarabine
3
Taxes
3
Radiation
3
Nivolumab
3
Irinotecan
3
Immunoglobulin G
3
Disulfides
3
tislelizumab
2
pemigatinib
2
olaparib
2
lenvatinib
2
futibatinib
2
dehydroftorafur
2
S 1 (combination)
2
Platinum
2
Liver Transplantation
2
Immune Checkpoint Inhibitors
2
Fluorodeoxyglucose F18
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
erdafitinib
×
90 days
×
Clear all
No trials found.